Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
March 11, 2002
- Committee to Propose Basic Policy for Science and Technology
March 11, 2002
- WORLD NEWS IN BRIEF
March 11, 2002
- IFN Prices to Be Cut by 25%
March 11, 2002
- Spin-off of Manufacturing Plants to Increase: PAL Revision
March 4, 2002
- 12,558 Drugstores Operated by 590 Companies: JACDS Survey
March 4, 2002
- Study Group Proposes Proper Drug Distribution System
March 4, 2002
- Taisho Appeals against Daikoku
March 4, 2002
- Manufacturers' FTC Issues Guide Regarding Entertainment
March 4, 2002
- Additional Premiums to Be Introduced in Medical Material Pricing System
March 4, 2002
- Kyowa Hakko to Transfer Its Liquor Business to Asahi Breweries
March 4, 2002
- Medical Devices to Be Re-priced to Reduce Domestic, Foreign Price Gaps
March 4, 2002
- Eisai's French Subsidiary Acquires All Shares of Biodim
March 4, 2002
- Fresenius-Kawasumi Completes 2nd Phase Construction on Inukai Plant
March 4, 2002
- Tsumura to Gear Up Kampo Business in China
March 4, 2002
- MEDICAL DEVICE NEWS IN BRIEF
March 4, 2002
- GE Information Supply Fee to Be Introduced: Revision -1-
March 4, 2002
- BUSINESS NEWS IN BRIEF
March 4, 2002
- WORLD NEWS IN BRIEF
March 4, 2002
- NEW PRODUCTS
March 4, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…